An upcoming international position statement will clarify the small number of patients for whom the MiniMed Implantable Infusion Pump might be considered appropriate.
The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.
A tear in the tubing may prevent users from getting full insulin doses. So far 18 people have reported serious issues related ...
Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...
In individuals with gestational diabetes, patient-led insulin titration is linked to faster glycemic control and a lower risk ...
Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...
Life with diabetes usually includes many injections of the blood sugar–controlling hormone insulin. Recent research investigating a once-weekly shot finds it might help lessen the burden a bit for ...
N.H., and Susan Collins, R-Maine, have introduced a bill that would, among other things, delay Medicare competitive bidding ...
University of Chicago researchers developed an mRNA nanoparticle system that triggers cells to produce PD-L1 protein, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results